March 10, 2011

Neurimmune introduced BIIB037

Neurimmune introduced BIIB037, a monoclonal antibody that Neurimmune’s partner Biogen Idec of Cambridge, Massachusetts, will push into human trials this year. At the 10th International AD/PD Conference in Barcelona, Spain, Neurimmune introduced BIIB037, a monoclonal antibody partnered with Biogen Idec of Cambridge, Massachusetts, for the teratment of Alzheimer’s disease.

Read more